
UAE Health Ministry ends birth and death certification service: What you need to know
In a sweeping administrative change, the UAE Ministry of Health and Prevention (MoHAP) has officially ended its role in issuing birth and death certificates. These vital registration services are now handled by Emirates Health Services (EHS) in the northern emirates, while Dubai and Abu Dhabi continue under their respective local health authorities.
Tired of too many ads? go ad free now
The transition was made quietly, with MoHAP removing all related service options from its website and discontinuing its WhatsApp-based application system. Residents are now required to navigate a decentralised process based on their emirate of residence.
What Has Changed?
MoHAP has withdrawn from issuing birth and death certificates.
Emirates Health Services (EHS) is now responsible in Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah, and Fujairah.
Dubai Health Authority (DHA) and Abu Dhabi's Department of Health (DoH) continue to manage services locally.
(DHA) and Abu Dhabi's Department of Health (DoH) continue to manage services locally. Certificates issued by EHS, DHA, or DoH are fully equivalent to those formerly issued by MoHAP.
BIRTH CERTIFICATES: How It Works Now
Who Can Apply?
Parents (of any nationality), legal guardians, or authorised delegates.
Where to Apply?
Via the EHS website (requires UAE Pass)
Through the Mabrouk Ma Yak platform (for Emiratis only)
At EHS public health centres or hospitals
Documents Needed:
Valid Emirates ID and passport for both parents
Hospital-issued, certified birth notification
Electronic civil record
Marriage certificate or notarised parentage document
For UAE citizens with births abroad:
Return tickets
ID and passports of both parents
Attested marriage certificate
For complex cases (e.g., prison births):
Court-issued documents
Letters from correctional facilities or social services
Birth notifications
Fees & Turnaround (Converted to INR)
Birth Certificate in Arabic: AED 65 (~₹1,470)
English Copy (optional): AED 65 (~₹1,470)
Time to Issue: 1 working day
DEATH CERTIFICATES: Procedure and Conditions
Who Can Apply?
Immediate family members or legally authorised persons.
Where to Apply?
Through the EHS online portal
At a designated public health centre or hospital
Documents Required:
Emirates ID or passport of the deceased
No Objection Certificate (NOC) from Ministry of Interior
Official death report
In suspicious or unknown-cause deaths: Forensic report
Name consistency across all documents is mandatory
International Use:
Certificates must be attested by the UAE Ministry of Foreign Affairs and International Cooperation and the embassy of the relevant foreign country.
Fees & Timelines (Converted to INR)
Death Certificate in Arabic: AED 65 (~₹1,470)
English Copy (optional): AED 65 (~₹1,470)
Time to Issue:
5 minutes for e-certificates
Physical copy available upon in-person visit
Service Hours
Monday to Thursday: 7:30 AM to 3:30 PM
Friday: 7:30 AM to 12:00 PM
Why the Change Matters
The UAE is continuing its trend of devolving administrative authority to regional bodies, particularly for citizen services. Emirates Health Services already manages most public healthcare in the northern emirates, making it a natural successor to MoHAP in handling life-event documentation.
The Bottom Line
The next time you need a birth or death certificate in the UAE, MoHAP is no longer your go-to authority. Depending on where you live, you'll be interacting with EHS, DHA, or DoH—with new procedures, slightly altered fees, and a greater push toward digital verification.
While the transition might be procedural, it signals a larger shift in how civil documentation is administered across the UAE—more digital, more localised, and firmly tied to regional health systems.
(Exchange rate used: 1 AED = ₹22.60)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
an hour ago
- Time of India
Axiom-4 astronauts to study insulin behaviour in microgravity, revolutionise diabetes treatment
New Delhi: Indian astronaut Shubhanshu Shukla's Axiom-4 mission to the International Space Station (ISS) is set to offer a ray of hope for diabetics to travel to space, as a UAE-based healthcare provider is conducting an experiment on how glucose behaves in microgravity part of the "Suite Ride" experiment planned by Burjeel Holdings and Axiom Space, some astronauts of the Axiom-4 mission will be wearing continuous glucose monitors during their 14-day stay on board the orbital lab. The studies of the behaviour of glucose and insulin in microgravity conditions will help scientists develop wearable technologies for astronauts and patients who are bedridden or have limited mobility due to illnesses such as paralysis. "We are trying just to see if there is any change or fluctuation to the blood-sugar levels while they are in space," Mohammad Fityan, chief medical officer at Burjeel Holdings, Abu Dhabi, told PTI. The astronauts will also carry insulin pens in refrigerated and ambient temperatures to examine how the molecules respond to microgravity conditions. "We are hoping that if we learn something about the metabolism or the effect, we will bring some information and we can do something for our patients on Earth," Fityan said. Currently, the National Aeronautics and Space Administration (NASA) does not allow insulin-dependent diabetics to travel to space. There are no official exclusions for non-insulin-dependent diabetics, but so far, no astronaut with diabetes has travelled to space. "It has the potential to transform the future of space travel for astronauts with insulin-dependent diabetes mellitus (IDDM), a condition historically considered disqualifying for space missions," Fityan said. He said the study will pave the way for several innovative technologies and treatment approaches for developing advanced glucose-monitoring tools optimised for extreme or low-activity environments, improving wearable tech for both astronauts and patients with limited mobility on Earth. It will also help identify new pharmacologic targets by observing how metabolic and hormonal responses change in microgravity, leading to drugs that enhance insulin sensitivity or mimic the benefits of exercise in sedentary individuals. The AI-powered predictive models based on real-time physiologic data in space can be adapted to personalise diabetes care on Earth by forecasting insulin needs or metabolic shifts with higher accuracy. The research will also help develop remote monitoring platforms for continuous metabolic-data capture that could revolutionise diabetes care in underserved or remote areas on Earth as well as in tele-health settings.


Time of India
2 hours ago
- Time of India
Major chocolate recall sweeps U.S stores — here's why your favorite sweet treat might be unsafe
Weaver Nut Company is recalling certain semi-sweet chocolate nonpareils distributed throughout the United States. If you recently purchased semi-sweet chocolate nonpareils from a grocery or retail store, you should double-check the lot number. Major chocolate recall sweeps U.S. stores: The U.S. Food and Drug Administration (FDA) announced in a news release on Wednesday that Weaver Nut Company was recalling its semi-sweet chocolate nonpareils with white or Christmas-colored seeds, with particular lot codes, due to possible unreported milk allergies, as per a report by Newsweek. Although no illnesses have been reported, people who are allergic to milk face a serious risk. The chocolates were sold through supermarkets and retail stores throughout the United States. ALSO READ: McDonald's boycott June 24: Who's behind it, why it's happening, and how long it will last Why is your favourite sweet treat unsafe? According to the FDA's release, the problem was discovered after a wholesale customer complained about differences in product specifications. Live Events The chocolates were labelled as being free of milk, but later laboratory testing revealed that they did contain milk proteins, it added. It further stated that consuming the affected items could result in severe or fatal allergic reactions for people with a milk allergy or severe sensitivity. One of the top nine allergens that the FDA requires to be declared is milk, and improper labelling can be very risky. Why is this recall important? According to the Pennsylvania-based Weaver Nut Company, the recall is a preventative step to protect the public's health. The business is taking all necessary steps to ensure the safety of its products. Which chocolates are affected? Customers are advised to verify product lot codes and return or dispose of any impacted items. Throw away the items or return them to the store for a complete refund. Lot numbers 204206, 204207, 204208, 204209, 204212, 224225 are for Item 47518-Nonpareil, Semi-Sweet Chocolate (Christmas Seeds). Lot numbers 204214-RL, 204214, 204215, 224221, 224222, 224223, 135215, 135216, 135217, 135220, 135221, 145204, 145205-1, 145207-1, and 145210-1 are for Item D2645, Nonpareils, Semi-Sweet Chocolate (White Seeds), as per a report by Newsweek. FAQs What do I do if I have these chocolates? Check the lot number, and if it is recalled, do not eat it. Return it for a refund or dispose of it. Why is the recall so serious? Milk is a major allergen, and consuming it when allergic can result in serious or life-threatening reactions. Economic Times WhatsApp channel )


Economic Times
5 hours ago
- Economic Times
Trump expands ban on transgender rights: VA denies fertility treatment for veterans under new rules
Transgender veterans barred from fertility treatment Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel When US President Donald Trump returned to the White House, one of his first acts was to sign an executive order to ban transgenders from participating in the military. Now months later, the Department of Veterans Affairs followed suit with a ban on medical insurance coverage for gender-affirming care, reports NewsWeek.A leaked email from a person at the Department of Veteran Affairs (VA) revealed that transgender veterans eligible for health benefits will no longer receive financial coverage for egg- and sperm-freezing fertility treatments. The email shows the department will no longer cover the costs for those transgender veterans preparing for gender dysphoria treatment and seeking cryopreservation. Dsyphoria treatment is a process in which eggs or sperm (gametes) are frozen and stored to be thawed for later since Donald Trump has returned to office, he has taken a slew of actions regarding transgender people, including signing an executive order stating that there are only two unchangeable sexes and another attempting to ban transgender women from competing in women's sports. He also signed an order aimed at restricting access to puberty blockers and other gender care for people under age 19 with some of his actions sparking legal challenges in the March, it was announced in the VA specifically that the department began phasing out treatment for gender dysphoria following Trump's executive order recognizing only two sexes. However, the VA stated that transgender veterans would still have access to VA health care the email now indicates a shift from the previous policy. "On yesterday's (6/16/2025) National Fertility Interdisciplinary Teams Office Hours call, it was announced that VA will no longer pay for cryopreservation of gametes for a medical indication if it involves transgender veterans seeking cryopreservation in preparation for treatment of Gender Dysphoria or Gender Identity Disorder. This will reportedly affect new authorizations and will not disrupt cryopreservation that has already been initiated," the email viewed by NewsWeek added that according to another senior official in the Veterans Health Administration "the change is reportedly already in effect and an official announcement will be forthcoming" and advised the department to "hold on authorizing any new cryopreservation for medical indications related to gender dysphoria/gender identity disorder" while waiting for further guidance."We want to avoid a situation where veterans could be told they are approved for cryo, only to find out after the fact that VA cannot pay for care they received," the email Keith, the founder and executive director of the Michigan-based transgender charity Stand With Trans, said the policy was "discrimination.""Clearly, the rights of the trans community are the target of attack," she told Newsweek. "It doesn't matter whether someone is an adult, a minor, a veteran, a professional, or other, if one is trans identified, they are seeing rights being taken away one by one. It is deplorable. If one class of people can receive treatment paid for with their benefits, then other classes of people should receive the same. This is why we have the equal protection clause in our Constitution."No one should be excluded from a particular treatment because they are transgender. This is the very definition of discrimination."This comes days after the Trump administration denied reporting by The Guardian that said new VA hospitals could refuse care to veterans based on factors like marital status and political affiliation due to an executive order by President Guardian earlier Monday published a report saying VA hospitals are implementing new rules in response to Trump's executive order in January, which would permit workers to deny care to veterans based on characteristics not protected by federal House deputy press secretary Anna Kelly adamantly denied The Guardian's reporting. Writing on social platform X, Kelly addressed the article's writer, Aaron Glantz, saying, 'Aaron, this is a totally FALSE story that The Guardian should retract immediately. Fearmongering with our Veterans to try to score clicks for your failing 'news outlet' is pathetic and shameful.'